How can I propose a research collaboration?

Submit the collaboration form on this page with your name, institutional email, affiliation, research area, and project description. Dr. Mennati reviews all proposals and responds within 5-10 business days to discuss feasibility and next steps.

What types of collaborations are accepted?

Accepted collaborations include joint research projects, postdoctoral fellowships, co-supervision of graduate students, institutional partnerships, and joint grant applications — focused on nanoparticle engineering, siRNA delivery, or computational oncology.

Can biological samples be exchanged for joint research?

Yes, but exclusively under formal Material Transfer Agreements and IRB ethics approval. Only de-identified, research-purpose samples from partner institutions are accepted — no clinical samples from individual patients.

What equipment and facilities are available?

The lab has access to cell culture facilities, flow cytometry, qRT-PCR, ELISA, nanoparticle characterization (DLS, zeta potential), and computational resources for molecular dynamics simulations and biosimulation modeling.

Can Dr. Mennati co-supervise my PhD or MSc thesis?

Yes, through formal co-supervision arrangements with your home institution. Submit your research proposal, current supervisor's approval, and timeline via the collaboration form for evaluation.

Global Research Call — 2026

Building the Future of Personalized Cancer Therapy — Together

The Mennati Research Lab invites researchers, universities, and institutions worldwide to collaborate on hybrid nanoparticle systems, siRNA delivery, and molecular cancer biosimulation. This page is designed exclusively for academic and scientific research partnerships.

Start a Collaboration See How It Works

Important Notice: This page is intended solely for academic and scientific research collaboration. It does not provide direct diagnostic or treatment services to patients. Biological samples are accepted exclusively under formal research collaboration agreements (IRB/ethics approval) and applicable regulatory permissions.

Open Invitation

Who We're Inviting

We welcome researchers, graduate students, principal investigators, and institutions worldwide to help shape the next generation of targeted cancer therapeutics.

Universities & Research Institutes

Joint projects in hybrid nanoparticle systems, siRNA delivery, and genomic sequencing across multi-site research initiatives.

Independent & Postdoc Researchers

Opportunities for co-authored publications, lab data exchange, and design of novel formulation protocols.

Bioinformatics & Computational Labs

Collaboration on biosimulation model development and genomic profile analysis for treatment-response prediction.

Health-Focused Nonprofits

Partnership on knowledge-sharing initiatives, training programs, and equitable access to emerging cancer therapeutics.

Collaboration Process

How a Partnership Begins

Every research collaboration follows a transparent, ethics-first pathway.

Initial Contact

Submit the collaboration form describing your research focus.

Scientific Review

Evaluation of project alignment with current lab objectives.

Formal Agreement

Drafting of MOU/research agreement and required ethics approvals.

Joint Project Launch

Collaboration begins; data/sample exchange per approved protocol.

Collaboration Form

Get in Touch

Please describe your research project or collaboration request. Our team will respond within 5–7 business days.

Full Name *

Institutional Email *

University / Institution *

Country *

Area of Interest *

Project Description / Collaboration Request *